Kala Bio KALA
NASDAQ KALA
$0.56 +0.02 (+3.50%)
At close: Sep 9, 2026 · 4:00 PM EDT

Kala Bio (KALA) Net Income (2016 - 2026)

Kala Bio's (KALA) quarterly Net Income came in at -$1.6 million in Q2 2026, up 86.49% year-over-year from -$847769.0 in Q2 2025, and up 8.51% quarter-over-quarter from -$1.7 million in Q1 2026.

Analysis

Kala Bio (KALA) Net Income (2016 - 2026) Analysis & Trends

Kala Bio has disclosed Net Income across 11 years of filings, most recently posting -$1.6 million for Q2 2026.

  • In Q2 2026, Net Income rose 86.49% year-over-year to -$1.6 million; the TTM figure through Jun 2026 stood at -$21.6 million (up 51.19% YoY), while the FY2025 annual figure was -$41.3 million, up 7.63% from the prior year.
  • Net Income came in at -$1.6 million for Q2 2026 at Kala Bio, up from -$1.7 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$1.6 million in Q2 2026 to a low of -$32.9 million in Q1 2022.
  • Average Net Income over 5 years is -$12.2 million, with a median of -$10.7 million recorded in 2024.
  • Year-over-year, Net Income dropped 14.54% in 2024 and soared 86.49% in 2026.
  • Over 5 years, Net Income stood at -$11.5 million in 2022, then increased by 8.69% to -$10.5 million in 2023, then gained by 0.99% to -$10.4 million in 2024, then climbed by 0.07% to -$10.4 million in 2025, then surged by 84.75% to -$1.6 million in 2026.
  • Per Business Quant data, the three most recent Net Income figures were -$1.6 million in Q2 2026, -$1.7 million in Q1 2026, and -$10.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 601.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 164.49 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 97.50 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -13.27 Mn
10 Kala Bio 7.80 Mn 7.80 Mn - -1.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.58 Mn
Mar 31, 2026 -1.73 Mn
Dec 31, 2025 -10.37 Mn
Sep 30, 2025 -7.93 Mn
Jun 30, 2025 -11.70 Mn
Mar 31, 2025 -11.30 Mn
Dec 31, 2024 -10.37 Mn
Sep 30, 2024 -10.90 Mn
Jun 30, 2024 -10.56 Mn
Mar 31, 2024 -12.88 Mn
Dec 31, 2023 -10.48 Mn
Sep 30, 2023 -9.51 Mn
Jun 30, 2023 -10.29 Mn
Mar 31, 2023 -12.48 Mn
Dec 31, 2022 -11.47 Mn
Sep 30, 2022 -15.78 Mn
Jun 30, 2022 -28.11 Mn
Mar 31, 2022 -32.94 Mn
Dec 31, 2021 -48.88 Mn
Sep 30, 2021 -28.13 Mn